titanium has been researched along with notoginsenoside r1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X; Sun, Y; Wang, J; Yan, L; Zhang, Z; Zhao, S | 1 |
1 other study(ies) available for titanium and notoginsenoside r1
Article | Year |
---|---|
Notoginsenoside R1 suppresses wear particle-induced osteolysis and RANKL mediated osteoclastogenesis in vivo and in vitro.
Topics: Animals; Arthroplasty, Replacement; Bone Resorption; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Ginsenosides; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteolysis; Postoperative Complications; Prosthesis Failure; RANK Ligand; RAW 264.7 Cells; Signal Transduction; Titanium | 2017 |